comprehensive -WSS

comprehensive

author：knowledge 2025-09-03 07:53:52 - browse：192

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： H5N1 bird flu outbreak: Second human case reported, in Michigan

hotspot

WSS

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

How dance can help health care workers heal from trauma

Medical experts are missing from AI regulatory conversations

Eyeing GLP

H5N1 virus can be tracked in retail milk, scientists say

explore

comprehensive

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Listen: More tumult at BIO & coercive care for sickle cell patients

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA poised to publish guidelines for clinical trial diversity

BioMarin wins approval for gene therapy to treat hemophilia A

Trump got a 'target letter.' What is one and what does it mean?

Psychedelics group wrestles with new pharma identity

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Drug repurposing or repositioning? The language matters

Listen: More tumult at BIO & coercive care for sickle cell patients

leisure time

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Digital health: a case of mistaken identity

Addressing health care workers' trauma can help fight burnout

Scrutiny of post

Listen: More tumult at BIO & coercive care for sickle cell patients

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

focus

leisure time

hotspot

explore